Exact Mass: 211.03755800000002
Exact Mass Matches: 211.03755800000002
Found 93 metabolites which its exact mass value is equals to given mass value 211.03755800000002
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Phosphocreatine
Phosphocreatine, also known as creatine phosphate (CP) or PCr (Pcr), is a phosphorylated creatine molecule that serves as a rapidly mobilizable reserve of high-energy phosphates in skeletal muscle, myocardium and the brain to recycle adenosine triphosphate, the energy currency of the cell. Phosphocreatine undergoes irreversible cyclization and dehydration to form creatinine at a fractional rate of 0.026 per day, thus forming approximately 2 g creatinine/day in an adult male. This is the amount of creatine that must be provided either from dietary sources or by endogenous synthesis to maintain the body pool of (creatine and) phosphocreatine. Creatine is an amino acid that plays a vital role as phosphocreatine in regenerating adenosine triphosphate in skeletal muscle to energize muscle contraction. Creatine is phosphorylated to phosphocreatine in muscle in a reaction that is catalyzed by the enzyme creatine kinase. This enzyme is in highest concentration in muscle and nerve. Oral administration increases muscle stores. During the past decade, creatine has assumed prominence as an ergogenic (and legal) aid for professional and elite athletes. Most (~ 95\\%) of the total body creatine-phosphocreatine pool is in muscle (more in skeletal muscle than in smooth muscle) and amounts to 120 g (or 925 mmol) in a 70 kg adult male. Approximately 60-67\\% of the content in resting muscle is in the phosphorylated form. This generates enough ATP at the myofibrillar apparatus to power about 4 seconds of muscle contraction in exercise. Phosphocreatine reacts with ADP to yield ATP and creatine; the reversible reaction is catalyzed by creatine kinase. phosphocreatine is the chief store of high-energy phosphates in muscle. Thus, this reaction, which permits the rephosphorylation of ADP to ATP, is the immediate source of energy in muscle contraction. During rest, metabolic processes regenerate phosphocreatine stores. In normal muscle, ATP that is broken down to ADP is immediately rephosphorylated to ATP. Thus, phosphocreatine serves as a reservoir of ATP-synthesizing potential. phosphocreatine is the only fuel available to precipitously regenerate ATP during episodes of rapid fluctuations in demand. The availability of phosphocreatine likely limits muscle performance during brief, high-power exercise, i.e., maximal exercise of short duration. With near maximal isometric contraction, the rate of utilization of phosphocreatine declines after 1-2 seconds of contraction, prior to the glycolysis peak at approximately 3 seconds (PMID:10079702). Phosphocreatine undergoes irreversible cyclization and dehydration to form creatinine at a fractional rate of 0.026 per day, thus forming approximately 2 g creatinine/day in an adult male. This is the amount of creatine that must be provided either from dietary sources or by endogenous synthesis to maintain the body pool of (creatine and) phosphocreatine. Creatine is an amino acid that plays a vital role as phosphocreatine in regenerating adenosine triphosphate in skeletal muscle to energize muscle contraction. Creatine is phosphorylated to phosphocreatine in muscle in a reaction that is catalyzed by the enzyme creatine kinase. This enzyme is in highest concentration in muscle and nerve. Oral administration increases muscle stores. During the past decade, creatine has assumed prominence as an ergogenic (and legal) aid for professional and elite athletes. Most (~ 95\\%) of the total body creatine-phosphocreatine pool is in muscle (more in skeletal muscle than in smooth muscle) and amounts to 120 g (or 925 mmol) in a 70 kg adult male. Approximately 60-67\\% of the content in resting muscle is in the phosphorylated form. This generates enough ATP at the myofibrillar apparatus to power about 4 seconds of muscle contraction in exercise. Phosphocreatine reacts with ADP to yield ATP and creatine; the reversible reaction is catalyzed by creatine kinase. phosphocreatine is the chief store of high-energy phosphates in muscle. Thus, this reaction, which permits the rephosphorylation of ADP to ATP, is the immediate source of energy in muscle contraction. During rest, metabolic processes regenerate phosphocreatine stores. In normal muscle, ATP that is broken down to ADP is immediately rephosphorylated to ATP. Thus, phosphocreatine serves as a reservoir of ATP-synthesizing potential. phosphocreatine is the only fuel available to precipitously regenerate ATP during episodes of rapid fluctuations in demand. The availability of phosphocreatine likely limits muscle performance during brief, high-power exercise, i.e., maximal exercise of short duration. With near maximal isometric contraction, the rate of utilization of phosphocreatine declines after 1-2 seconds of contraction, prior to the glycolysis peak at approximately 3 seconds. (PMID: 10079702, Nutr Rev. 1999 Feb;57(2):45-50.) [HMDB] D020011 - Protective Agents > D002316 - Cardiotonic Agents C - Cardiovascular system > C01 - Cardiac therapy D002317 - Cardiovascular Agents KEIO_ID P084; [MS2] KO009218 KEIO_ID P084
2-[Carbamimidoyl(phosphonomethyl)amino]acetic acid
Pyridin-2-carbonsaeuremethylester-6-monothiocarbonsaeure-S-methylester|pyridine-2-carboxylic acid methyl ester 6-carbothioic acid S-methyl ester
7-hydroxy-5-hydroxymethyl-2h-benzo[1,4]thiazin-3-one
A benzothiazine that is 2H-1,4-benzothiazin-3(4H)-one substituted by a hydroxy and a hydroxymethyl group at positions 7 and 5 respectively. It is an antibacterial agent from Ampelomyces.
Phosphocreatine
D020011 - Protective Agents > D002316 - Cardiotonic Agents C - Cardiovascular system > C01 - Cardiac therapy D002317 - Cardiovascular Agents
3-(6-CHLORO-PYRIDIN-3-YL)-ACRYLIC ACID ETHYL ESTER
Benzoyl chloride, 4-[(dimethylamino)carbonyl]- (9CI)
N-(1H-benzoimidazol-2-yl)methanesulfonamide
C8H9N3O2S (211.04154540000002)
4-(3,4-Methylenedioxyphenyl)-3-thiosemicarbazide
C8H9N3O2S (211.04154540000002)
3H-Pyrazolo[4,3-c]pyridin-3-one, 1,2,4,5,6,7-hexahydro-, hydrochloride (1:2)
4-(4-Carboxyphenyl)-3-thiosemicarbazide
C8H9N3O2S (211.04154540000002)
Chlorthenoxazine
C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic
ETHYL 5-HYDROXY-3-METHYL-4-ISOXAZOLE-CAR BOXYLATE, SODIUM SALT H2O
C7H10NNaO5 (211.04566499999999)
1-methyl-3-(4-nitrophenyl)thiourea
C8H9N3O2S (211.04154540000002)
(S)-2,2,2-Trifluoro-1-phenylethylamine hydrochloride
C8H9ClF3N (211.03755800000002)
2,2,2-Trifluoro-1-phenylethanamine hydrochloride
C8H9ClF3N (211.03755800000002)
3-(2-CHLORO-PYRIDIN-4-YL)-ACRYLIC ACID ETHYL ESTER
3-(2-chloro-pyridin-3-yl)-acrylic acid ethyl ester
4-CHLORO-6,7-DIHYDRO-5H-CYCLOPENTA[B]PYRIDIN-7-YLACETATE
1H-Indol-7-ol, 1-(chloroacetyl)-2,3-dihydro- (9CI)
4-methyl-2,3-dihydro-1,4-benzoxazine-7-carbonyl chloride
Thiomorpholine-3-carboxylic acid ethyl ester hydrochloride
2-(ETHYLAMINO)THIAZOLO[4,5-B]PYRIDINE-5,7-DIOL
C8H9N3O2S (211.04154540000002)
7-CHLORO-2,3-DIHYDRO-5-METHOXYBENZO[F][1,4]OXAZEPINE
Aminosalicylate Sodium
C7H10NNaO5 (211.04566499999999)
J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis > J04AA - Aminosalicylic acid and derivatives D000893 - Anti-Inflammatory Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D012459 - Salicylates D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D000995 - Antitubercular Agents C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent
1-methyl-1-(4-nitrophenyl)thiourea
C8H9N3O2S (211.04154540000002)
Benzenemethanamine, 2,3,4,5,6-pentafluoro-a-methyl-, (aS)
(6-Methoxy-pyridin-3-yl)-hydrazine dihydrochloride
2-amino-7-oxo-4,5,6,7-tetrahydro-1-benzothiophene-3-carboxylic acid
Lithium (2-chloro-5-methoxypyridin-4-yl)trihydroxyborate
(R)-2,2,2-TRIFLUORO-1-PHENYLETHANAMINE HYDROCHLORIDE
C8H9ClF3N (211.03755800000002)
N-(3-cyanopyridin-2-yl)-N-methylmethanesulfonamide
C8H9N3O2S (211.04154540000002)
2H-1,4-Benzoxazine, 4-(chloroacetyl)-3,4-dihydro- (8CI,9CI)
3-[(Cyclopropylcarbonyl)amino]-2-thiophenecarboxylic acid
N-Phosphocreatine
A phosphoamino acid consisting of creatine having a phospho group attached at the primary nitrogen of the guanidino group.